Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease

Overview of attention for article published in Respiratory Research, August 2005

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 68 Dimensions

Readers on

mendeley: 70 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 68 publications that cite this research output.

68

The most recent citing publications are shown below. View all 68 publications that cite this research output on Dimensions.

Unraveling the Underlying Molecular Mechanism of ‘Silent Hypoxia’ in COVID-19 Patients Suggests a Central Role for Angiotensin II Modulation of the AT1R-Hypoxia-Inducible Factor Signaling Pathway

Article in Journal of Clinical Medicine (March 2023)

Novel and emerging therapies in pulmonary arterial hypertension

Article in Frontiers in Drug Discovery (December 2022)

The impact of COVID-19 on populations living at high altitude: Role of hypoxia-inducible factors (HIFs) signaling pathway in SARS-CoV-2 infection and replication

Article in Frontiers in Physiology (August 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.